Litwin, Mark S.
Burnett School of Medicine,
United States
2025 Rank: 73290
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 467 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73290 | 85139 |
| Total Cites | 986 | 1035 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 210 | 210 |
| Number of Single+First+Last Authored Papers | 261 | 261 |
| Total Cites to Single+First+Last Authored Papers | 431 | 445 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 842 | 873 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.19 |
| Self-Citation Percentage |
4.73%
|
|
Litwin, Mark S.
David Geffen School of Medicine at UCLA,
United States
2024 Rank: 56409
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 362 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56409 | 58253 |
| Total Cites | 1109 | 1176 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 72 | 72 |
| Total Cites to Single+First Authored Papers | 279 | 282 |
| Number of Single+First+Last Authored Papers | 258 | 258 |
| Total Cites to Single+First+Last Authored Papers | 508 | 527 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 924 | 958 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.23 |
| Self-Citation Percentage |
5.70%
|
|
Litwin, Mark S.
David Geffen School of Medicine at UCLA,
United States
2023 Rank: 56437
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 409 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56437 | 63433 |
| Total Cites | 1150 | 1236 |
| H-index | 12 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 264 | 271 |
| Number of Single+First+Last Authored Papers | 253 | 253 |
| Total Cites to Single+First+Last Authored Papers | 529 | 558 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 994 | 1033 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
6.96%
|
|
Litwin, Mark S.
University of California, Los Angeles,
United States
2022 Rank: 35284
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 246 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35284 | 39698 |
| Total Cites | 1250 | 1308 |
| H-index | 14 | 14 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 297 | 303 |
| Number of Single+First+Last Authored Papers | 245 | 245 |
| Total Cites to Single+First+Last Authored Papers | 585 | 606 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1019 | 1050 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
4.43%
|
|
Litwin, Mark S.
University of California, Los Angeles,
United States
2021 Rank: 30614
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 206 out of 76322 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30614 | 34487 |
| Total Cites | 1935 | 2024 |
| H-index | 17 | 17 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 405 | 412 |
| Number of Single+First+Last Authored Papers | 245 | 245 |
| Total Cites to Single+First+Last Authored Papers | 879 | 915 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1578 | 1623 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
4.40%
|
|
Litwin, Mark S.
David Geffen School of Medicine at UCLA,
United States
2020 Rank: 36882
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 272 out of 64516 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36882 | 38421 |
| Total Cites | 1491 | 1570 |
| H-index | 15 | 15 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 3 | 4 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 285 | 291 |
| Number of Single+First+Last Authored Papers | 243 | 243 |
| Total Cites to Single+First+Last Authored Papers | 679 | 703 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1193 | 1234 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.27 |
| Self-Citation Percentage |
5.03%
|
|